Mill Creek Capital Advisors »

Amgen shares owned by Mill Creek Capital Advisors

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Mill Creek Capital Advisors from 13F filings

Historical chart of Mill Creek Capital Advisors investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Mill Creek Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Mill Creek Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.0M 3.8k 268.76
2023-06-30 $899k 4.0k 222.02
2023-03-31 $1.3M 5.5k 241.75
2022-12-31 $985k 3.7k 262.64

More positions owned by Mill Creek Capital Advisors

Vanguard Value Etf Etf (VTV)
Vanguard Growth Etf Etf (VUG)
Ishares Core Msci Total International Stock Etf Etf (IXUS)
Hartford Multifactor Developed Markets Ex Us Etf (RODM)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Vanguard Small Cap Value Etf Etf (VBR)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Franklin U.s. Low Volatility High Dividend Index Etf Etf (LVHD)
Ishares Msci Eafe Small-cap Etf Etf (SCZ)
Vanguard S&p 500 Etf Etf (VOO)
Ishares U.s. Treasury Bond Etf Etf (GOVT)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Small-cap Growth Etf Etf (VBK)
Vanguard Total Corporate Bond Etf Etf (VTC)
Johnson & Johnson Stock (JNJ)

View all positions for Mill Creek Capital Advisors

Top funds holding Amgen

Vanguard Group
PRIMECAP Management Company
Charles Schwab Investment Management
Wells Fargo & Company
T. Rowe Price Associates
Royal Bank of Canada
Bank of New York Mellon
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
UBS Group
Goldman Sachs Group
Jpmorgan Chase & Co
Ubs Global Asset Management Americas
Barclays

View all funds holding Amgen